Clinical chemistry and laboratory medicine最新文献

筛选
英文 中文
Is uracil enough for effective pre-emptive DPD testing? 尿嘧啶是否足以进行有效的先期 DPD 检测?
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-07-19 DOI: 10.1515/cclm-2024-0742
Niels Heersche, Maja Matic, Ron H J Mathijssen, Marieke J H Coenen, Ron H N van Schaik
{"title":"Is uracil enough for effective pre-emptive DPD testing?","authors":"Niels Heersche, Maja Matic, Ron H J Mathijssen, Marieke J H Coenen, Ron H N van Schaik","doi":"10.1515/cclm-2024-0742","DOIUrl":"https://doi.org/10.1515/cclm-2024-0742","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141632854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of cardiovascular risk and physical activity: the role of cardiac-specific biomarkers in the general population and athletes. 心血管风险和体力活动评估:心脏特异性生物标志物在普通人群和运动员中的作用。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-07-18 DOI: 10.1515/cclm-2024-0596
Aldo Clerico, Martina Zaninotto, Alberto Aimo, Claudio Galli, Maria Teresa Sandri, Mario Correale, Ruggero Dittadi, Marco Migliardi, Antonio Fortunato, Lucia Belloni, Mario Plebani
{"title":"Assessment of cardiovascular risk and physical activity: the role of cardiac-specific biomarkers in the general population and athletes.","authors":"Aldo Clerico, Martina Zaninotto, Alberto Aimo, Claudio Galli, Maria Teresa Sandri, Mario Correale, Ruggero Dittadi, Marco Migliardi, Antonio Fortunato, Lucia Belloni, Mario Plebani","doi":"10.1515/cclm-2024-0596","DOIUrl":"https://doi.org/10.1515/cclm-2024-0596","url":null,"abstract":"<p><p>The first part of this Inter-Society Document describes the mechanisms involved in the development of cardiovascular diseases, particularly arterial hypertension, in adults and the elderly. It will also examine how consistent physical exercise during adolescence and adulthood can help maintain blood pressure levels and prevent progression to symptomatic heart failure. The discussion will include experimental and clinical evidence on the use of specific exercise programs for preventing and controlling cardiovascular diseases in adults and the elderly. In the second part, the clinical relevance of cardiac-specific biomarkers in assessing cardiovascular risk in the general adult population will be examined, with a focus on individuals engaged in sports activities. This section will review recent studies that suggest a significant role of biomarkers in assessing cardiovascular risk, particularly the presence of cardiac damage, in athletes who participate in high-intensity sports. Finally, the document will discuss the potential of using cardiac-specific biomarkers to monitor the effectiveness of personalized physical activity programs (Adapted Physical Activity, APA). These programs are prescribed for specific situations, such as chronic diseases or physical disabilities, including cardiovascular diseases. The purposes of this Inter-Society Document are the following: 1) to discuss the close pathophysiological relationship between physical activity levels (ranging from sedentary behavior to competitive sports), age categories (from adolescence to elderly age), and the development of cardiovascular diseases; 2) to review in detail the experimental and clinical evidences supporting the role of cardiac biomarkers in identifying athletes and individuals of general population at higher cardiovascular risk; 3) to stimulate scientific societies and organizations to develop specific multicenter studies that may take into account the role of cardiac biomarkers in subjects who follow specific exercise programs in order to monitor their cardiovascular risk.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141626135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction of negative-interference from calcium dobesilate in the Roche sarcosine oxidase creatinine assay using CuO. 使用氧化铜校正罗氏肌氨酸氧化酶肌酐测定法中多贝西拉钙的负干扰。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-07-17 DOI: 10.1515/cclm-2024-0471
Meng Zhao, Jiabao Fan, Panpan Lv, Zhengqi Zhu, Zhen Zhao
{"title":"Correction of negative-interference from calcium dobesilate in the Roche sarcosine oxidase creatinine assay using CuO.","authors":"Meng Zhao, Jiabao Fan, Panpan Lv, Zhengqi Zhu, Zhen Zhao","doi":"10.1515/cclm-2024-0471","DOIUrl":"https://doi.org/10.1515/cclm-2024-0471","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141619498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EFLM Task Force Preparation of Labs for Emergencies (TF-PLE) recommendations for reinforcing cyber-security and managing cyber-attacks in medical laboratories. EFLM 实验室应急准备工作组(TF-PLE)关于加强医学实验室网络安全和管理网络攻击的建议。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-07-17 DOI: 10.1515/cclm-2024-0803
Giuseppe Lippi, Salome Akhvlediani, Janne Cadamuro, Elisa Danese, Luis García de Guadiana Romualdo, Herve Delacour, Emmanuel J Favaloro, Julien Favresse, Brandon M Henry, Snezana Jovicic, Marge Kütt, Laetitia Moreno Y Banuls, Tomris Ozben, Avi Peretz, Antonija Perovic, Jecko Thachil, Dogan Yucel, Mario Plebani
{"title":"EFLM Task Force Preparation of Labs for Emergencies (TF-PLE) recommendations for reinforcing cyber-security and managing cyber-attacks in medical laboratories.","authors":"Giuseppe Lippi, Salome Akhvlediani, Janne Cadamuro, Elisa Danese, Luis García de Guadiana Romualdo, Herve Delacour, Emmanuel J Favaloro, Julien Favresse, Brandon M Henry, Snezana Jovicic, Marge Kütt, Laetitia Moreno Y Banuls, Tomris Ozben, Avi Peretz, Antonija Perovic, Jecko Thachil, Dogan Yucel, Mario Plebani","doi":"10.1515/cclm-2024-0803","DOIUrl":"https://doi.org/10.1515/cclm-2024-0803","url":null,"abstract":"<p><p>The healthcare systems are a prime target for cyber-attacks due to the sensitive nature of the information combined with the essential need for continuity of care. Medical laboratories are particularly vulnerable to cyber-attacks for a number of reasons, including the high level of information technology (IT), computerization and digitization. Based on reliable and widespread evidence that medical laboratories may be inadequately prepared for cyber-terrorism, a panel of experts of the Task Force Preparation of Labs for Emergencies (TF-PLE) of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) has recognized the need to provide some general guidance that could help medical laboratories to be less vulnerable and better prepared for the dramatic circumstance of a disruptive cyber-attack, issuing a number of consensus recommendations, which are summarized and described in this opinion paper.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141619499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Simplified preanalytical laboratory procedures for therapeutic drug monitoring (TDM) in patients treated with high-dose methotrexate (HD-MTX) and glucarpidase. 对接受大剂量甲氨蝶呤(HD-MTX)和葡萄糖苷酶治疗的患者进行治疗药物监测(TDM)的简化分析前实验室程序。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-07-15 DOI: 10.1515/cclm-2024-0523
Franz L Knörnschild, Sven Liebig, Peggy Kießling, Monika Prpic, Tehyung Kim, Ulrich Keller, Kai Kappert, Stefan Schwartz, Amir Jahic
{"title":"Simplified preanalytical laboratory procedures for therapeutic drug monitoring (TDM) in patients treated with high-dose methotrexate (HD-MTX) and glucarpidase.","authors":"Franz L Knörnschild, Sven Liebig, Peggy Kießling, Monika Prpic, Tehyung Kim, Ulrich Keller, Kai Kappert, Stefan Schwartz, Amir Jahic","doi":"10.1515/cclm-2024-0523","DOIUrl":"10.1515/cclm-2024-0523","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141598784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The surveys on quality indicators for the total testing process in clinical laboratories of Fujian Province in China from 2018 to 2023. 2018-2023年中国福建省临床实验室检验全过程质量指标调查。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-07-12 DOI: 10.1515/cclm-2024-0495
Yao Li, Falin Chen, Xijun Chen
{"title":"The surveys on quality indicators for the total testing process in clinical laboratories of Fujian Province in China from 2018 to 2023.","authors":"Yao Li, Falin Chen, Xijun Chen","doi":"10.1515/cclm-2024-0495","DOIUrl":"https://doi.org/10.1515/cclm-2024-0495","url":null,"abstract":"<p><strong>Objectives: </strong>This study investigates the application of 15 Quality Indicators (QIs) in clinical laboratories in Fujian Province, China, from 2018 to 2023. It identifies the main causes of laboratory errors and explores issues in the application of QIs, providing a reference for establishing provincial state-of-the-art and operational quality specifications (QSs).</p><p><strong>Methods: </strong>All clinical laboratories in Fujian Province were organized to submit general information and original QIs data through the online External Quality Assessment (EQA) system of the National Clinical Laboratory Center (NCCL) for a survey of 15 QIs. Data from 2018 to 2023 were downloaded for statistical analysis, and the current QSs for the 15 QIs in Fujian Province were compared and analyzed with those published by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Working Group on Laboratory Errors and Patient Safety (WG-LEPS).</p><p><strong>Results: </strong>QIs data from 542 clinical laboratories were collected. The survey on data sources showed that the number of laboratories recording QIs data using Laboratory Information Systems (LIS) increased annually, but the growth was modest and the proportion was less than 50 %. Among the laboratories using LIS to record QIs data, 133 continuously participated in this survey for six years, reporting different QIs. Over the six years, all reported QIs showed significant improvement or at least remained stable. The best median Sigma (σ) metrics were for the percentage of critical values notification and timely critical values notification, reaching 6σ, followed by the percentage of incorrect laboratory reports, with σ metrics ranging from 4.9σ to 5.1σ. In contrast, the percentage of tests covered by internal quality control (IQC) (1.5σ-1.7σ) and inter-laboratory comparison (0.1σ) remained consistently low. Compared to the QSs published by IFCC WG-LEPS, the QSs for the 15 QIs in Fujian Province in 2023 were stricter or roughly equivalent, except for the percentage of incorrect laboratory reports (Fujian Province: 0-0.221, IFCC WG-LEPS: 0-0.03).</p><p><strong>Conclusions: </strong>1. The application of QIs has significantly improved the quality of testing in clinical laboratories in Fujian Province, but the percentage of tests covered by IQC and inter-laboratory comparison remain low; 2. Effective application of QIs requires the establishment of comprehensive LIS, unified calculation standards, and other supporting measures.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141579140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Performance evaluation of a smartphone-based home test for fecal calprotection. 基于智能手机的家庭粪便热量保护测试性能评估。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-07-12 DOI: 10.1515/cclm-2024-0422
Simon Michaelis, Anna Hochfellner, Christopher Schneider, Wolfgang J Schnedl, Andreas Baranyi, Dietmar Enko
{"title":"Performance evaluation of a smartphone-based home test for fecal calprotection.","authors":"Simon Michaelis, Anna Hochfellner, Christopher Schneider, Wolfgang J Schnedl, Andreas Baranyi, Dietmar Enko","doi":"10.1515/cclm-2024-0422","DOIUrl":"https://doi.org/10.1515/cclm-2024-0422","url":null,"abstract":"<p><strong>Objectives: </strong>Fecal calprotectin (FC) serves as a non-invasive marker for the assessment of gut inflammation in patients with inflammatory bowel disease (IBD). Laboratory measurements are usually performed with immunologic methods like enzyme-linked immunosorbent assay. Recently, quantitative home tests based on the lateral flow technology with smartphones as read-out devices have been developed. We compared the quantitative and qualitative performance of the quantitative lateral flow home test Preventis SmarTest<sup>®</sup> Calprotectin Home and the immunological test used in our laboratory (Eurospital Calprest<sup>®</sup> Turbo).</p><p><strong>Methods: </strong>Fourty-five routine samples were analyzed in parallel with both tests according to the manufacturer's instructions. The read-out of the home test was performed with two smartphones (Apple iPhone 14 Pro and Samsung Galaxy XCover 5). The qualitative interpretation (positive, negative, borderline) was conducted using the cut-offs provided by the manufacturers.</p><p><strong>Results: </strong>Statistically significant correlations with the laboratory standard method were observed for both smartphones (Spearman's rho 0.703 and 0.715, all p<0.005). The home test showed systematically higher concentrations compared to the routine assay. We found minimal qualitative agreement between the two tests (Cohen's kappas (κ)=0.323 and 0.300; p=0.003 and 0.005) showing a lower rate of positives with the home test. Both used smartphones showed good quantitative and qualitative agreement.</p><p><strong>Conclusions: </strong>The tests are quantitatively not interchangeable. However, the home test may be applicable for the serial follow-up management of patients with IBD. The higher rate of samples classified as negative with the home test may lead to an underestimation of affected patients.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141579115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The biological variation of insulin resistance markers: data from the European Biological Variation Study (EuBIVAS). 胰岛素抵抗标志物的生物变异:欧洲生物变异研究(EuBIVAS)的数据。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-07-12 DOI: 10.1515/cclm-2024-0672
Anna Carobene, Eric Kilpatrick, William A Bartlett, Pilar Fernández Calle, Abdurrahman Coşkun, Jorge Díaz-Garzón, Niels Jonker, Massimo Locatelli, Sverre Sandberg, Aasne K Aarsand
{"title":"The biological variation of insulin resistance markers: data from the European Biological Variation Study (EuBIVAS).","authors":"Anna Carobene, Eric Kilpatrick, William A Bartlett, Pilar Fernández Calle, Abdurrahman Coşkun, Jorge Díaz-Garzón, Niels Jonker, Massimo Locatelli, Sverre Sandberg, Aasne K Aarsand","doi":"10.1515/cclm-2024-0672","DOIUrl":"https://doi.org/10.1515/cclm-2024-0672","url":null,"abstract":"<p><strong>Objectives: </strong>An insulin resistant state is characteristic of patients with type 2 diabetes, polycystic ovary syndrome, and metabolic syndrome. Identification of insulin resistance (IR) is most readily achievable using formulae combining plasma insulin and glucose results. In this study, we have used data from the European Biological Variation Study (EuBIVAS) to examine the biological variability (BV) of IR using the Homeostasis Model Assessment for Insulin Resistance (HOMA-IR) and the Quantitative Insulin sensitivity Check Index (QUICKI).</p><p><strong>Methods: </strong>Ninety EuBIVAS non-diabetic subjects (52F, 38M) from five countries had fasting HOMA-IR and QUICKI calculated from plasma glucose and insulin samples collected concurrently on 10 weekly occasions. The within-subject (CV<sub>I</sub>) and between-subject (CV<sub>G</sub>) BV estimates with 95 % CIs were obtained by CV-ANOVA after analysis of trends, variance homogeneity and outlier removal.</p><p><strong>Results: </strong>The CV<sub>I</sub> of HOMA-IR was 26.7 % (95 % CI 25.5-28.3), driven largely by variability in plasma insulin and the CV<sub>I</sub> for QUICKI was 4.1 % (95 % CI 3.9-4.3), reflecting this formula's logarithmic transformation of glucose and insulin values. No differences in values or BV components were observed between subgroups of men or women below and above 50 years.</p><p><strong>Conclusions: </strong>The EuBIVAS, by utilising a rigorous experimental protocol, has produced robust BV estimates for two of the most commonly used markers of insulin resistance in non-diabetic subjects. This has shown that HOMA-IR, in particular, is highly variable in the same individual which limits the value of single measurements.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141579116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New generation of Abbott enzyme assays: imprecision, methods comparison, and impact on patients' results. 新一代雅培酶标仪:不精确性、方法比较及对患者结果的影响。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-07-10 DOI: 10.1515/cclm-2024-0627
Marc Chévrier, Audrey Frugier, Sylvie Colognac, Denis Monneret
{"title":"New generation of Abbott enzyme assays: imprecision, methods comparison, and impact on patients' results.","authors":"Marc Chévrier, Audrey Frugier, Sylvie Colognac, Denis Monneret","doi":"10.1515/cclm-2024-0627","DOIUrl":"https://doi.org/10.1515/cclm-2024-0627","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141562785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EFLM Task Force Preparation of Labs for Emergencies (TF-PLE) survey on cybersecurity. EFLM 紧急情况实验室准备工作组(TF-PLE)网络安全调查。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-07-04 DOI: 10.1515/cclm-2024-0727
Giuseppe Lippi, Janne Cadamuro, Elisa Danese, Emmanuel J Favaloro, Julien Favresse, Brandon M Henry, Snezana Jovicic, Tomris Ozben, Jecko Thachil, Mario Plebani
{"title":"EFLM Task Force Preparation of Labs for Emergencies (TF-PLE) survey on cybersecurity.","authors":"Giuseppe Lippi, Janne Cadamuro, Elisa Danese, Emmanuel J Favaloro, Julien Favresse, Brandon M Henry, Snezana Jovicic, Tomris Ozben, Jecko Thachil, Mario Plebani","doi":"10.1515/cclm-2024-0727","DOIUrl":"https://doi.org/10.1515/cclm-2024-0727","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141491141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信